tradingkey.logo
tradingkey.logo
Search

Onkure Therapeutics Inc

OKUR
Add to Watchlist
4.125USD
+0.135+3.38%
Close 08-17 16:00ETQuotes delayed by 15 min
166.44MMarket Cap
LossP/E TTM

OKUR Financials

See Onkure Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Onkure Therapeutics Inc Earnings Date

Latest Release
Aug 4, 2026
EPS / Forecast
-0.31/-0.54
Revenue / Forecast
--/166.67K
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-4.40
71.18%
Analyst Rating
BUY
2026/08/17
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
72.99%-0.31
6.56%-1.11
89.40%-0.99
90.16%-1.09
28.98%-1.14
96.09%-1.19
-33.38%-9.36
-94.52%-11.04
75.18%-1.60
-403.28%-30.37
-26.82%-7.02
---5.68
---6.46
---6.03
---5.54
---15.67
----
----
----
----
Net Profit
0.29%-15.35M
4.82%-15.16M
61.63%-13.50M
-298.13%-14.70M
-187.07%-15.39M
-67.00%-15.93M
-49.42%-35.19M
80.77%-3.69M
72.55%-5.36M
36.88%-9.54M
-73.19%-23.55M
-47.58%-19.20M
-58.63%-19.53M
-15.89%-15.11M
-28.22%-13.60M
-2.14%-13.01M
-33.59%-12.31M
-80.75%-13.04M
-69.63%-10.61M
-150.00%-12.73M
Operating profit
-3.52%-16.90M
8.15%-15.62M
58.20%-14.13M
-232.35%-15.50M
-156.51%-16.32M
-72.92%-17.00M
-35.15%-33.80M
77.67%-4.66M
69.75%-6.36M
39.02%-9.83M
-71.72%-25.01M
-50.92%-20.89M
-69.25%-21.04M
-23.88%-16.12M
-37.07%-14.56M
-8.53%-13.84M
-34.71%-12.43M
-80.41%-13.02M
-69.96%-10.62M
-150.09%-12.75M
Net Profit
0.29%-15.35M
4.82%-15.16M
61.63%-13.50M
-298.13%-14.70M
-187.07%-15.39M
-67.00%-15.93M
-49.42%-35.19M
80.77%-3.69M
72.55%-5.36M
36.88%-9.54M
-73.19%-23.55M
-47.58%-19.20M
-58.63%-19.53M
-15.89%-15.11M
-28.22%-13.60M
-2.14%-13.01M
-33.59%-12.31M
-80.75%-13.04M
-69.63%-10.61M
-150.00%-12.73M
Current assets
110.14%177.68M
101.16%197.48M
-46.16%60.84M
-7.11%71.53M
8.41%84.55M
16.97%98.17M
5.98%113.00M
-40.21%77.00M
-46.70%77.99M
-13.49%83.93M
0.25%106.62M
6.42%128.77M
10.84%146.32M
-32.02%97.02M
-30.82%106.35M
-25.62%121.00M
-22.86%132.01M
52.54%142.72M
--153.73M
--162.66M
Total current liabilities
-12.56%6.64M
63.11%14.33M
-43.77%5.92M
92.33%6.25M
463.58%7.60M
212.19%8.79M
-42.07%10.53M
-76.05%3.25M
-90.19%1.35M
-73.15%2.81M
155.15%18.18M
43.52%13.56M
64.82%13.74M
32.50%10.48M
14.87%7.12M
48.75%9.45M
149.85%8.34M
101.27%7.91M
--6.20M
--6.35M
Total assets
108.38%179.35M
98.93%198.69M
-45.94%62.12M
-6.19%72.83M
9.34%86.07M
18.01%99.88M
6.95%114.91M
-40.45%77.64M
-46.83%78.72M
-14.39%84.64M
-0.69%107.44M
6.44%130.39M
10.80%148.04M
-31.54%98.87M
-29.76%108.18M
-24.82%122.50M
-22.01%133.61M
51.50%144.41M
--154.02M
--162.94M
Total liabilities
-8.34%7.25M
55.31%14.34M
-46.45%5.93M
76.65%6.41M
327.71%7.90M
171.83%9.23M
-41.15%11.08M
-76.52%3.63M
-88.09%1.85M
-71.17%3.40M
129.25%18.83M
47.66%15.44M
64.12%15.51M
29.58%11.78M
20.53%8.21M
55.29%10.46M
151.83%9.45M
129.53%9.09M
--6.81M
--6.74M
Total equity
120.18%172.11M
103.37%184.35M
-45.89%56.18M
-10.25%66.43M
1.69%78.17M
11.58%90.65M
17.17%103.83M
-35.61%74.02M
-42.00%76.87M
-6.71%81.24M
-11.36%88.61M
2.59%114.94M
6.74%132.53M
-35.64%87.08M
-32.09%99.97M
-28.27%112.05M
-25.90%124.16M
48.12%135.32M
--147.21M
--156.21M
Net operating income
22.00%-10.35M
7.62%-12.94M
45.22%-11.51M
-471.55%-13.04M
-95.01%-13.27M
-31.76%-14.01M
-6.39%-21.02M
87.85%-2.28M
57.76%-6.81M
-17.47%-10.63M
-26.52%-19.75M
-73.87%-18.77M
-34.78%-16.11M
-0.54%-9.05M
-55.80%-15.61M
-11.60%-10.79M
-23.25%-11.96M
-4.77%-9.00M
-85.20%-10.02M
-68.47%-9.67M
Net investment
-75823.08%-9.87M
72.22%-5.00K
99.98%-9.00K
-100.02%-6.00K
-100.06%-13.00K
-100.00%-18.00K
-214.08%-45.38M
17.65%25.00M
132.59%22.49M
-100.05%-9.00K
247.77%39.78M
146.77%21.25M
-859.78%-69.01M
241.02%18.51M
-430.15%-26.92M
-907.65%-45.44M
133.65%9.08M
21808.00%5.43M
51056.25%8.15M
-477.95%-4.51M
Net financing
---5.38M
189709.09%146.00M
-99.79%240.00K
-100.00%0.00
100.00%0.00
-870.00%-77.00K
2866.91%114.22M
1056.07%2.00M
-100.14%-89.00K
-99.01%10.00K
-1370.15%-4.13M
78.35%173.00K
148297.67%63.81M
16716.67%1.01M
173.11%325.00K
-56.31%97.00K
-99.95%43.00K
-99.99%6.00K
-99.75%119.00K
335.29%222.00K

FAQs

What are the current assets of Onkure Therapeutics Inc?

According to Onkure Therapeutics Inc's FY2025 earnings report, its current assets were 60.84M, with a year-on-year change of -46.16.

What are the total assets of Onkure Therapeutics Inc?

According to Onkure Therapeutics Inc's FY2025 earnings report, its total assets of Onkure Therapeutics Inc were 62.12M, with a year-on-year change of -45.94.

What are the total liabilities of Onkure Therapeutics Inc?

According to Onkure Therapeutics Inc's FY2025 earnings report, its total liabilities of Onkure Therapeutics Inc were 5.93M, with a year-on-year change of -46.45.

What is the total equity of Onkure Therapeutics Inc?

According to Onkure Therapeutics Inc's FY2025 earnings report, its total equity of Onkure Therapeutics Inc was 56.18M, with a year-on-year change of -45.89.

What is the net operating income of Onkure Therapeutics Inc?

According to Onkure Therapeutics Inc's FY2025 earnings report, its net operating income of Onkure Therapeutics Inc was -62.95M, with a year-on-year change of -15.75.

What is the net investment of Onkure Therapeutics Inc?

According to Onkure Therapeutics Inc's FY2025 earnings report, its net investment of Onkure Therapeutics Inc was -46.00K, with a year-on-year change of -100.29.

What is the net financing of Onkure Therapeutics Inc?

According to Onkure Therapeutics Inc's FY2025 earnings report, its net financing of Onkure Therapeutics Inc was 163.00K, with a year-on-year change of -99.86.

What is the Earnings Per Share (EPS) of Onkure Therapeutics Inc?

According to Onkure Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -4.40, with a year-on-year change of 71.18.

What is the net income of Onkure Therapeutics Inc?

According to Onkure Therapeutics Inc's FY2025 earnings report, its net income was -59.52M, with a year-on-year change of -12.99.

What is the Return on Equity (ROE) of Onkure Therapeutics Inc?

According to Onkure Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -74.39, with a year-on-year change of -35.89.

What is the Return on Assets (ROA) of Onkure Therapeutics Inc?

According to Onkure Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -67.24, with a year-on-year change of -41.92.

What is the operating profit of Onkure Therapeutics Inc?

According to Onkure Therapeutics Inc's FY2025 earnings report, its operating profit was -62.95M, with a year-on-year change of -15.75.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.